Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
A 2021 study examined digestive side effects in people with overweight or obesity who received semaglutide in clinical trials
Clinical data showed A1C reduction of 2.02% in diabetic participants, triglyceride reduction of 28%, systolic blood pressure reduction of 6.8 mmHg, LDL cholesterol reduction of 12%, and liver fat reduction of 44% measured by MRI
Active ingredient: Semaglutide 0.5 mg Inactive ingredients: Disodium phosphate dihydrate 1.42 mg Propylene glycol 14.0 mg Phenol 5.50 mg (preservative) Water for injection pH: Approx
Gen Z users were especially likely to substitute drug and alcohol use with exercise (61%), while others turned to sleep (44%) or self-reflection practices like journaling and therapy (41%) to lessen their intake
:max_bytes(150000):strip_icc():focal(748x241:750x243)/Serena-Williams-1-012726-2698f17c5ab647929a79194c436d85ea.jpg)
